DossierENTITY

Relfydess

Coverage of Relfydess in the Nexus archive.

Earliest in view: Jul 1 · 07:54 UTCMost recent: Jul 1 · 07:54 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 1 · 07:54 UTCBLOOMBERG
Galderma Slumps After FDA Turns Down Botox Rival Relfydess
Galderma's stock declined following the FDA's rejection of Relfydess, a Botox competitor. The decision negatively impacted the company's market performance.